Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)

To facilitate the achieving of the goal of “eliminating viral hepatitis as a major public health threat by 2030” set by the World Health Organization, the Chinese Society of Hepatology together with the Chinese Society of Infectious Diseases (both are branches of the Chinese Medical Association) org...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Hong, Wang, Fusheng, Li, Taisheng, Xu, Xiaoyuan, Sun, Yameng, Nan, Yuemin, Wang, Guiqiang, Hou, Jinlin, Duan, Zhongping, Wei, Lai, Jia, Jidong, Zhuang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2023
Materias:
Guideline
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500285/
https://www.ncbi.nlm.nih.gov/pubmed/37719965
http://dx.doi.org/10.14218/JCTH.2023.00320
_version_ 1785105888334315520
author You, Hong
Wang, Fusheng
Li, Taisheng
Xu, Xiaoyuan
Sun, Yameng
Nan, Yuemin
Wang, Guiqiang
Hou, Jinlin
Duan, Zhongping
Wei, Lai
Jia, Jidong
Zhuang, Hui
author_facet You, Hong
Wang, Fusheng
Li, Taisheng
Xu, Xiaoyuan
Sun, Yameng
Nan, Yuemin
Wang, Guiqiang
Hou, Jinlin
Duan, Zhongping
Wei, Lai
Jia, Jidong
Zhuang, Hui
author_sort You, Hong
collection PubMed
description To facilitate the achieving of the goal of “eliminating viral hepatitis as a major public health threat by 2030” set by the World Health Organization, the Chinese Society of Hepatology together with the Chinese Society of Infectious Diseases (both are branches of the Chinese Medical Association) organized a panel of experts and updated the guidelines for prevention and treatment of chronic hepatitis B in China (version 2022). With the support of available evidence, this revision of the guidelines focuses on active prevention, large scale testing, and expansion of therapeutic indication of chronic hepatitis B with the aim of reducing the hepatitis B related disease burden.
format Online
Article
Text
id pubmed-10500285
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher XIA & HE Publishing Inc.
record_format MEDLINE/PubMed
spelling pubmed-105002852023-09-15 Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022) You, Hong Wang, Fusheng Li, Taisheng Xu, Xiaoyuan Sun, Yameng Nan, Yuemin Wang, Guiqiang Hou, Jinlin Duan, Zhongping Wei, Lai Jia, Jidong Zhuang, Hui J Clin Transl Hepatol Guideline To facilitate the achieving of the goal of “eliminating viral hepatitis as a major public health threat by 2030” set by the World Health Organization, the Chinese Society of Hepatology together with the Chinese Society of Infectious Diseases (both are branches of the Chinese Medical Association) organized a panel of experts and updated the guidelines for prevention and treatment of chronic hepatitis B in China (version 2022). With the support of available evidence, this revision of the guidelines focuses on active prevention, large scale testing, and expansion of therapeutic indication of chronic hepatitis B with the aim of reducing the hepatitis B related disease burden. XIA & HE Publishing Inc. 2023-11-28 2023-08-15 /pmc/articles/PMC10500285/ /pubmed/37719965 http://dx.doi.org/10.14218/JCTH.2023.00320 Text en © 2023 Authors. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Guideline
You, Hong
Wang, Fusheng
Li, Taisheng
Xu, Xiaoyuan
Sun, Yameng
Nan, Yuemin
Wang, Guiqiang
Hou, Jinlin
Duan, Zhongping
Wei, Lai
Jia, Jidong
Zhuang, Hui
Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)
title Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)
title_full Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)
title_fullStr Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)
title_full_unstemmed Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)
title_short Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)
title_sort guidelines for the prevention and treatment of chronic hepatitis b (version 2022)
topic Guideline
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500285/
https://www.ncbi.nlm.nih.gov/pubmed/37719965
http://dx.doi.org/10.14218/JCTH.2023.00320
work_keys_str_mv AT youhong guidelinesforthepreventionandtreatmentofchronichepatitisbversion2022
AT wangfusheng guidelinesforthepreventionandtreatmentofchronichepatitisbversion2022
AT litaisheng guidelinesforthepreventionandtreatmentofchronichepatitisbversion2022
AT xuxiaoyuan guidelinesforthepreventionandtreatmentofchronichepatitisbversion2022
AT sunyameng guidelinesforthepreventionandtreatmentofchronichepatitisbversion2022
AT nanyuemin guidelinesforthepreventionandtreatmentofchronichepatitisbversion2022
AT wangguiqiang guidelinesforthepreventionandtreatmentofchronichepatitisbversion2022
AT houjinlin guidelinesforthepreventionandtreatmentofchronichepatitisbversion2022
AT duanzhongping guidelinesforthepreventionandtreatmentofchronichepatitisbversion2022
AT weilai guidelinesforthepreventionandtreatmentofchronichepatitisbversion2022
AT jiajidong guidelinesforthepreventionandtreatmentofchronichepatitisbversion2022
AT zhuanghui guidelinesforthepreventionandtreatmentofchronichepatitisbversion2022
AT guidelinesforthepreventionandtreatmentofchronichepatitisbversion2022

Ejemplares similares